40 results on '"Landay, Alan L."'
Search Results
2. HIV and comorbidities – the importance of gut inflammation and the kynurenine pathway.
3. Obesity in HIV infection: host-pathogen interaction.
4. Elevated CD4 + T-cell glucose metabolism in HIV+ women with diabetes mellitus.
5. Gut Microbiota, Plasma Metabolomic Profiles, and Carotid Artery Atherosclerosis in HIV Infection.
6. Circulating CD4+ TEMRA and CD4+ CD28- T cells and incident diabetes among persons with and without HIV.
7. Chronic HIV Infection and Aging: Application of a Geroscience-Guided Approach.
8. Plasma galectin-9 as a predictor of adverse non-AIDS events in persons with chronic HIV during suppressive antiretroviral therapy.
9. Subclinical Carotid Artery Atherosclerosis Is Associated With Increased Expression of Peripheral Blood IL-32 Isoforms Among Women Living With HIV.
10. Overt IL-32 isoform expression at intestinal level during HIV-1 infection is negatively regulated by IL-17A.
11. Nonclassical Monocytes (CD14dimCD16+) Are Associated With Carotid Intima-Media Thickness Progression for Men but Not Women: The Multi-Ethnic Study of Atherosclerosis—Brief Report.
12. Association of Monocyte Migration Marker CD11b With Pulmonary Function in People Living With HIV.
13. Elevated Microparticle Tissue Factor Activity Is Associated With Carotid Artery Plaque in HIV-Infected Women.
14. Plasma acylcarnitines and progression of carotid artery atherosclerosis in HIV infection.
15. Elevated Plasma Ceramides Are Associated With Antiretroviral Therapy Use and Progression of Carotid Artery Atherosclerosis in HIV Infection.
16. A compartmentalized type I interferon response in the gut during chronic HIV-1 infection is associated with immunopathogenesis.
17. HIV and aging: role of the microbiome.
18. Inflammatory Colonic Innate Lymphoid Cells Are Increased During Untreated HIV-1 Infection and Associated With Markers of Gut Dysbiosis and Mucosal Immune Activation.
19. Effect of CMV and EBV replication on intestinal mucosal gene expression and microbiome composition of HIV-infected and uninfected individuals.
20. Higher Body Mass Index Is Associated With Greater Proportions of Effector CD8+ T Cells Expressing CD57 in Women Living With HIV.
21. Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation.
22. Association of cognitive activity and neurocognitive function in blacks and whites with HIV.
23. Increased glucose transporter-1 expression on intermediate monocytes from HIV-infected women with subclinical cardiovascular disease.
24. CD14brightCD16- monocytes and sCD14 level negatively associate with CD4-memory T-cell frequency and predict HCV-decline on therapy.
25. Differential CD4+ cell count increase and CD4+ : CD8+ ratio normalization with maraviroc compared with tenofovir.
26. Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects.
27. Does systemic inflammation and immune activation contribute tofracture risk in HIV?
28. A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virus.
29. The Safety and Immunogenicity of an Interleukin-12-Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection.
30. Exploratory comparison of vaginal glycogen and Lactobacillus levels in premenopausal and postmenopausal women.
31. Viremic and Virologically Suppressed HIV Infection Increases Age-Related Changes to Monocyte Activation Equivalent to 12 and 4 Years of Aging, Respectively.
32. HIV-associated mucosal gene expression: region-specific alterations.
33. Association of Chronic Hepatitis C Infection With T-Cell Phenotypes in HIV-Negative and HIV-Positive Women.
34. A Randomized Controlled Trial of Palifermin (Recombinant Human Keratinocyte Growth Factor) for the Treatment of Inadequate CD4+ T-Lymphocyte Recovery in Patients with HIV-1 Infection on Antiretroviral Therapy.
35. Soluble CD163 is associated with noninvasive measures of liver fibrosis in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected women.
36. The immunogenicity of an HIV-1 Gag conserved element DNA vaccine in people with HIV and receiving antiretroviral therapy.
37. Tryptophan metabolism, gut microbiota, and carotid artery plaque in women with and without HIV infection.
38. Regulatory CD4 + T Cells Recognize Major Histocompatibility Complex Class II Molecule-Restricted Peptide Epitopes of Apolipoprotein B.
39. Effect of cytomegalovirus and Epstein-Barr virus replication on intestinal mucosal gene expression and microbiome composition of HIV-infected and uninfected individuals.
40. Does systemic inflammation and immune activation contribute to fracture risk in HIV?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.